# MBX Biosciences, Inc. (MBX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from MBX Biosciences, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/MBX/mda/fy2025/): filed 2026-03-12; accession 0001193125-26-103121 (https://www.sec.gov/Archives/edgar/data/1776111/000119312526103121/mbx-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/MBX/mda/fy2024/): filed 2025-03-17; accession 0000950170-25-039838 (https://www.sec.gov/Archives/edgar/data/1776111/000095017025039838/mbx-20241231.htm)

Back to /company/MBX/